Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Keros Therapeutics, Inc. See All Filings	D	2020-03-12 15:15:24 UTC
Amount To Be Raised $56,000,057 Associated Brokers / Dealers N/A CIK Number 0001664710 Filed Document 0001664710-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-03-12 15:15:24 UTC Type of Offering D Industry Other Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Keros Therapeutics, Inc. See All Filings	D	2018-11-21 08:16:36 UTC
Amount To Be Raised $22,999,928 Associated Brokers / Dealers N/A CIK Number 0001664710 Filed Document 0001664710-18-000001 Exclusions or Exemptions 506b Accepted Date 2018-11-21 08:16:36 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Keros Therapeutics, Inc. See All Filings	D/A	2017-11-13 13:54:49 UTC
Amount To Be Raised $11,000,000 Associated Brokers / Dealers N/A CIK Number 0001664710 Filed Document 0001664710-17-000002 Exclusions or Exemptions 506b Accepted Date 2017-11-13 13:54:49 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Keros Therapeutics, Inc. See All Filings	D/A	2016-08-18 16:37:12 UTC
Amount To Be Raised $11,000,078 Associated Brokers / Dealers N/A CIK Number 0001664710 Filed Document 0001664710-16-000002 Exclusions or Exemptions 506b Accepted Date 2016-08-18 16:37:12 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Keros Therapeutics, Inc. See All Filings	D	2016-04-28 00:00:00 UTC
Amount To Be Raised $10,000,078 Associated Brokers / Dealers N/A CIK Number 0001664710 Filed Document 0001664710-16-000001 Exclusions or Exemptions 506b Accepted Date 2016-04-28 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity